(Q61907440)

English

Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Pilot Study to Assess the Antiviral Activity and Safety of Besifovir Dipivoxil 150mg and L-carnitine 660mg Compared to Tenofovir Alafenamide 25mg in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver (English)

0 references

0 references

0 references

0 references

metabolic dysfunction–associated steatotic liver disease

0 references

start time

23 September 2018

0 references

end time

30 July 2020

0 references

number of participants

76

0 references

research intervention

tenofovir

0 references

clinical trial phase

phase IV clinical trial

0 references

minimum age

20 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03604016

0 references

(Q61907440)

Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)